SEI INVESTMENTS CO - SAGE THERAPEUTICS INC ownership

SAGE THERAPEUTICS INC's ticker is SAGE and the CUSIP is 78667J108. A total of 232 filers reported holding SAGE THERAPEUTICS INC in Q3 2020. The put-call ratio across all filers is 0.62 and the average weighting 0.2%.

Quarter-by-quarter ownership
SEI INVESTMENTS CO ownership history of SAGE THERAPEUTICS INC
ValueSharesWeighting
Q2 2023$228,286
-40.2%
4,855
-46.7%
0.00%
-100.0%
Q1 2023$381,882
+19.0%
9,101
+10.9%
0.00%0.0%
Q3 2022$321,000
+39.0%
8,207
+14.4%
0.00%
Q2 2022$231,000
-92.6%
7,172
-86.9%
0.00%
-100.0%
Q2 2021$3,128,000
-20.5%
54,860
+5.8%
0.01%
-30.0%
Q1 2021$3,937,000
-9.0%
51,847
+3.2%
0.01%
-9.1%
Q4 2020$4,327,000
+93.5%
50,224
+37.1%
0.01%
+83.3%
Q3 2020$2,236,000
+88.9%
36,639
+28.6%
0.01%
+50.0%
Q2 2020$1,184,000
+95.4%
28,482
+29.5%
0.00%
+100.0%
Q1 2020$606,000
-74.2%
22,000
-32.8%
0.00%
-71.4%
Q4 2019$2,345,000
-74.2%
32,739
-49.4%
0.01%
-69.6%
Q3 2019$9,073,000
-21.0%
64,708
+3.2%
0.02%
-39.5%
Q2 2019$11,484,000
+29.0%
62,679
+11.8%
0.04%
+26.7%
Q1 2019$8,900,000
+1288.5%
56,039
+1067.0%
0.03%
+1400.0%
Q4 2018$641,000
+3.1%
4,802
+8.2%
0.00%0.0%
Q3 2018$622,000
-64.7%
4,437
-60.6%
0.00%
-66.7%
Q2 2018$1,764,000
+176300.0%
11,274
+225380.0%
0.01%
Q1 2018$1,000
-99.6%
5
-99.9%
0.00%
-100.0%
Q3 2016$263,000
+3657.1%
5,702
+2336.8%
0.00%
Q2 2016$7,0000.0%234
+7.3%
0.00%
Q1 2016$7,000
-46.2%
218
-3.5%
0.00%
Q4 2015$13,000
-94.8%
226
-96.2%
0.00%
-100.0%
Q3 2015$250,000
-31.7%
5,916
+18.0%
0.00%
-33.3%
Q2 2015$366,000
+49.4%
5,015
+2.6%
0.00%
+50.0%
Q1 2015$245,000
+12150.0%
4,890
+7787.1%
0.00%
Q4 2014$2,000620.00%
Other shareholders
SAGE THERAPEUTICS INC shareholders Q3 2020
NameSharesValueWeighting ↓
RTW INVESTMENTS, LP 5,149,482$105,976,3402.24%
Palo Alto Investors LP 1,005,776$20,698,8701.96%
Boxer Capital, LLC 1,094,000$22,514,5201.20%
Bellevue Group AG 3,513,351$72,304,7641.16%
PDT Partners, LLC 181,625$3,737,8430.47%
EASTERLY INVESTMENT PARTNERS LLC 195,643$4,026,3330.44%
Harvest Investment Services, LLC 30,302$623,6150.40%
Simplify Asset Management Inc. 120,030$2,470,2170.28%
SAMLYN CAPITAL, LLC 739,867$15,226,4630.25%
CAXTON ASSOCIATES LP 68,035$1,400,1600.19%
View complete list of SAGE THERAPEUTICS INC shareholders